NRX PHARMACEUTICALS INC (NRXP) Stock News

USA - NASDAQ:NRXP - US6294442099 - Common Stock

3.2 USD

+0.05 (+1.59%)

Last: 10/23/2025, 8:21:17 PM

3.3 USD

+0.1 (+3.12%)

After Hours: 10/23/2025, 8:21:17 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

NRXP Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: NRx Pharmaceuticals, Inc.

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

4 days ago - By: NRx Pharmaceuticals, Inc.

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

12 days ago - By: ACCESS Newswire - Mentions: RDZN

New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group

18 days ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

2 months ago - By: Benzinga

Insights Ahead: NRX Pharmaceuticals's Quarterly Earnings

18 days ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference

25 days ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine

25 days ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine

a month ago - By: ACCESS Newswire

New to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free Ketamine

a month ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine

a month ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine

2 months ago - By: NRx Pharmaceuticals, Inc.

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

2 months ago - By: NRx Pharmaceuticals, Inc.

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics

2 months ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

2 months ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8th

2 months ago - By: NRx Pharmaceuticals, Inc.

UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

2 months ago - By: NRx Pharmaceuticals, Inc.

UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

2 months ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

2 months ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital

2 months ago - By: ACCESS Newswire - Mentions: TONX LASE MFH SNYR ...

New to The Street T.V. Broadcasting on Bloomberg Saturday Aug 30th. The episode features TON Strategy Company (NASDAQ: TONX), Laser Photonics (NASDAQ: LASE), Sullivan & Cromwell Senior M&A Partner Frank Aquila, and Mercurity Fintech (NASDAQ: MFH)

2 months ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

2 months ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)

2 months ago - By: Benzinga - Mentions: CSCI EVOK NXL ZYME ...

12 Health Care Stocks Moving In Friday's After-Market Session

2 months ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

2 months ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update

2 months ago - By: NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Second Quarter 2025 Financial Results Release to August 19, 2025

2 months ago - By: Stocktwits

Why Small-Cap Biotech NRx Pharmaceuticals Is Drawing Heavy Retail Buzz